华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03069 华夏恒生生科

未开盘 10-23 16:08:09

14.570

+0.200

+1.39%

最高14.680	最低13.990	成交量823.50万
今开14.200	昨收14.370	日振幅4.80%
总市值34.39亿	流通市值34.39亿	总股本2.36亿
成交额1.17亿	换手率3.49%	流通股本2.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03069","market":"HK","secType":"STK","nameCN":"华夏恒生生科","latestPrice":14.57,"timestamp":1792742889006,"preClose":14.37,"halted":0,"volume":8234973,"delay":0,"changeRate":0.013917884481558878,"floatShares":236000000,"shares":236000000,"eps":0,"marketStatus":"未开盘","change":0.2,"latestTime":"10-23 16:08:09","open":14.2,"high":14.68,"low":13.99,"amount":117011497,"amplitude":0.048017,"askPrice":14.57,"askSize":100,"bidPrice":14.56,"bidSize":1300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":0,"adr":0,"listingDate":1615996800000,"exchange":"SEHK","adjPreClose":14.37,"sharesOutstanding":237400000,"nav":14.5695,"aum":0,"dividendRate":0.003432,"bidAskSpread":0,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":1.2329846438389016,"lotSize":100,"spreadScale":3,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03069","defaultTab":"news","newsList":[{"id":"2677086546","title":"赛默飞世尔（TMO）Q3营收121亿美元同比增9% 生物制药板块收入69亿美元增15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677086546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677086546?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:55","pubTimestamp":1792594548,"startTime":"0","endTime":"0","summary":"金吾财讯 | 赛默飞世尔 披露2026年第三季度财报，整体业绩优于市场预期，核心驱动力来自实验室产品及生物制药服务板块的亮眼表现。公司总部位于马萨诸塞州沃尔瑟姆，三季度营收 121亿美元，同比增约9%，超出市场一致预期1.9亿美元；其中实验室产品和生物制药服务业务营收69亿美元，同比增长约15%，分析师此前预期为66亿美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"307468","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","MRNY","03069","IBBQ","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675989425","title":"智飞生物：专一、专注、专业地在生物制药领域深耕","url":"https://stock-news.laohu8.com/highlight/detail?id=2675989425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675989425?lang=zh_cn&edition=full","pubTime":"2026-10-16 17:33","pubTimestamp":1792143205,"startTime":"0","endTime":"0","summary":"证券之星消息，智飞生物(300122)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，公司维持上市公司的目的和意义是什么？智飞生物回复：您好，公司专一、专注、专业地在生物制药领域深耕，聚焦生产经营稳健发展，持续开展产品创新，巩固核心竞争力；优化市场营销策略，提升商业推广效能；同时完善治理体系，强化全过程质量管理，为企业长远发展奠定坚实基础。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600030035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","LU1064131003.USD","BK0196","LU1064130708.USD","BK0188","LU2580892862.HKD","300122","BK1610","03069","LU2148510915.USD","BK0239","LU2580892789.USD","LU1328615791.USD","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675992340","title":"美国生物制药公司Liquidia股价飙升41%，创2023年12月以来最大盘中涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2675992340","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675992340?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:35","pubTimestamp":1791984900,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！\n名额有限，手慢无。让我们共赴可持续之约！【点击报名】每经AI快讯，10月14日，美国生物制药公司Liquidia股价飙升41%，创2023年12月以来最大盘中涨幅。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-10-14/doc-inivffth4448528.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-10-14/doc-inivffth4448528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1610","IBBQ","03069","MRNY","MRNX","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675152853","title":"小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物及信达生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2675152853","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675152853?lang=zh_cn&edition=full","pubTime":"2026-10-14 14:30","pubTimestamp":1791959400,"startTime":"0","endTime":"0","summary":"模拟交易客户端10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！该行覆盖的逾20只中国生物科技股上周下跌4.4%，跑输恒生指数升1.8%。ESMO论文摘要预计于10月18日美东时间晚上6时发布，海报预计于10月23日上线，ESMO会议于10月23至27日举行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-10-14/doc-iniveqvs1150233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1610","IE00B1BXHZ80.USD","LU0211328371.USD","LU1366192091.USD","VFH","LU0868494708.USD","LU0203345920.USD","LU1119994496.HKD","LU0251132253.USD","IE00BKDWB100.SGD","LU0196878994.USD","LU0417517546.SGD","LU2237443465.HKD","01801","LU0211326839.USD","KURE","UYG","LU2462157665.USD","LU2552382132.HKD","BK1589","FTXO","LU0106261372.USD","LU0640476718.USD","LU0787776722.HKD","LU0211327993.USD","KBWB","LU1363072403.SGD","JPO","IE00BHPRN162.USD","JPMO","BK4566","LU2756315318.SGD","06990","TFNS","XLF","LU0943347566.SGD","FNCL","IE00BKVL7J92.USD","LU0157215616.USD","LU0267386448.USD","LU0942090050.USD","TRUF","LU2505996509.AUD","03069","IYF","LU2242644610.SGD","IYG","IE00B775SV38.USD","LU1267930490.SGD","IXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675311143","title":"小摩：中国生物科技ESMO催化剂可验证本土创新 首选科伦博泰生物(06990.HK)信达生物(01801.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675311143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675311143?lang=zh_cn&edition=full","pubTime":"2026-10-13 15:50","pubTimestamp":1791877833,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0149534421.HKD","LU1969619763.USD","BK1161","LU2328871848.SGD","BK1610","LU0326950275.SGD","LU2242644610.SGD","LU1188198961.HKD","BK1589","LU2097828805.USD","LU2097828557.USD","LU0196878994.USD","LU0463099449.HKD","LU1831875114.USD","LU2097828631.EUR","LU0607220059.USD","LU0455707207.USD","KURE","LU0244354667.USD","HK0000165453.HKD","BK1583","LU2488822045.USD","LU2097828714.EUR","03069","01801","06990","LU2097828474.EUR","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865591","title":"美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674865591?lang=zh_cn&edition=full","pubTime":"2026-10-10 00:21","pubTimestamp":1791562908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Retension Pharmaceuticals(RTSN.US)登陆美股市场，截至发稿，该股跌超10%，报10.77美元。IPO价格为12美元。Retension Pharmaceuticals是一家美国临床阶段生物制药公司，专注于开发治疗高血压及其他心血管疾病的创新药物。公司的核心在研药物RTN-001是一款新一代磷酸二酯酶5(PDE5)抑制剂，主要针对血压未得到有效控制及难治性高血压患者，目前正开展IIb期临床试验。该药物通过增强血管中的一氧化氮信号传导，帮助血管舒张、降低血压，其全球独家开发许可来自法国制药巨头赛诺菲安万特(SNY.US)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNX","RTSN","03069","MRNY","BK1610","BBP","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673099928","title":"ETF日报(10.07)丨半导体医药回调 加密资产相关反向产品逆市走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2673099928","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673099928?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:48","pubTimestamp":1791362920,"startTime":"0","endTime":"0","summary":"行业表现半导体与医药生物两大前期主线集体回调，是当日港股主要拖累。杠杆及跨境产品走势分化，半导体主题杠杆产品领跌全市场。加密资产相关反向产品逆势走强。做空类产品全线上行，印证大市调整方向。黄金主题产品小幅回调，高息与备兑策略产品表现分化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","LU0572944931.SGD","LU0620787316.HKD","LU2328871848.SGD","HYNX","MSTP","09115","SKHX","LU0228659784.USD","LU0314109678.HKD","SMH","03466","BK1098","03069","03417","03486","LU1969619763.USD","BK1587","LU1580142542.USD","LU0828238088.HKD","MCHmain","LU2289578879.USD","03423","BK4585","HK0000320264.USD","LU1997245177.USD","HK0000320223.HKD","LU2778985437.USD","BK4535","LU1880383440.USD","MSTX","HSCEI","03033","07299","BK0102","MSTZ","HSTECH","03037","07399","LU1303224171.USD","03067","LU2039709279.SGD","BK1610","01548","HK0000306701.USD","BK1583","MSII","LU1251922891.USD","LU1781817850.SGD","BK0214","07709","LU1880383366.USD","07226","LU1997245094.SGD","02828","BK0125","07200","LU1979443071.USD","07552","BK4588","03419","LU1719994722.HKD","03416","SGXZ49509284.SGD","LU1813983027.USD","SKHU","07588","BK1521","BK1611","MSTR","LU2495084118.USD","SMST","MSTW","03032","SKHA","03174","09088","HSI","SKDD","SKHL","LU0082770016.SGD","BK1576","WNTR","HK0000306685.HKD","LU2476274308.USD","LU0456842615.SGD","LU0588546209.SGD","LU0211977185.USD","07500","LU1328277881.USD","MTYY","SMHU","02837","MSTY","83115","MSST","06809","LU1770034418.SGD","03170","LU0274383008.USD","03046","09067","SKHN","82800","LU0307460666.USD","03110","SKUU","LU1934453819.USD","LU1997244956.HKD","LU0164939612.USD","03986","07300","02800","03115","MST","07747","LU2476274720.SGD","LU0269904917.USD","LU2213484517.USD","SK","03119","LU0509642566.USD","SKHQ","MSTC","MSDD","02840","SKHY","07311","MSTU","LU0828237510.HKD","SKHZ","03068","MSTK","BK1256","03121","07288","LU0082770016.USD","603986","IMST","BK0132","688008","82828","07799","SGXZ81163826.USD","03088","00823","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672268507","title":"生物制药公司Agenus报告称，其BOT+BAL联合疗法在复发性卵巢癌患者中取得了48% 的估计三年生存率。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672268507","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672268507?lang=zh_cn&edition=full","pubTime":"2026-10-03 23:04","pubTimestamp":1791039869,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["MRNX","03069","BK1610","BBP","IBBQ","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671564271","title":"科创板收盘播报：科创综指跌1.81% 生物制药股涨幅靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671564271","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671564271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:34","pubTimestamp":1790753669,"startTime":"0","endTime":"0","summary":"新华财经北京9月30日电（罗浩）科创50指数和科创综指30日早间分别以0.46%和0.56%的涨幅高开。两股指早盘期间整体呈震荡下行态势，午后窄幅整理，收盘时均大幅下跌。截至收盘，科创50指数报1530.01点，跌幅2.51%，成分股总成交额约719亿元，成交额较上一交易日小幅放量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["IBBQ","BK1610","MRNY","MRNX","000680.SH","BBP","03069","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278515","title":"ETF异动 | AI制药赛道热度高涨 华夏恒生生科(03069)盘中涨超4% 华夏创新药(03525)午后涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278515","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671278515?lang=zh_cn&edition=full","pubTime":"2026-09-30 13:44","pubTimestamp":1790747084,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，AI制药ETF延续近期涨势，截至发稿，华夏恒生生科涨3.58%，报16.8港元；华夏创新药涨2.95%，报10.48港元。消息面上，AI制药赛道热度高涨，AI4S正从“算力与模型”加速走向生物医药产业兑现。由OpenAI参投的生物科技初创公司Red Queen Bio计划于明年正式启动抗体药物的人体试验。同日，金斯瑞与礼来AI药物发现平台达成协作，公开资料显示，华夏恒生生科聚焦港股生物科技产业链，较大比例布局生命科学工具及服务企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU1152091168.USD","LU0359201885.HKD","LU1993786604.SGD","QTOC","01276","LU1951186391.HKD","LU1807302812.USD","01548","BK1521","ARTY","IE00BZ08YR35.GBP","LU0314109678.HKD","AIPO","LU0326950275.SGD","LU0359202008.SGD","KURE","LU1960683339.HKD","LU0501845795.SGD","BK1191","SG9999004220.SGD","01093","HK0000165453.HKD","AGIX","03525","IE00B543WZ88.USD","HK0000306685.HKD","03069","LU1226287792.SGD","BK4550","IE0008368742.USD","LU1226287875.USD","IE00BZ08YT58.USD","LU1226287529.USD","LU2039709279.SGD","LU1813983027.USD","BK4585","IE00B031HY20.USD","LU0072913022.USD","HK0000320223.HKD","LU0067412154.USD","IE00BZ08YS42.EUR","VTHR","BK1610","CHAT","FDN","01477","BK1576","IE0008369823.USD","LU1152091754.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670401110","title":"股市必读：中国医药（600056）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670401110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670401110?lang=zh_cn&edition=full","pubTime":"2026-09-28 03:39","pubTimestamp":1790537950,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，中国医药报收于8.86元，下跌1.12%，换手率0.5%，成交量7.49万手，成交额6649.31万元。董秘最新回复投资者： 请问公司三季度是否会开业绩说明会，投资者急着与公司交流董秘： 您好！当日关注点交易信息汇总：9月24日主力资金净流入73.17万元，占总成交额1.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK1610","BK0188","BK0082","BK0185","600056","03069","BK0250","BK0175","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669635144","title":"中国医药：全面推进科技创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2669635144","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669635144?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:30","pubTimestamp":1790238636,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：联合湖北丽益、则正科技同步推进前沿创新药研发进程,请问这个创新药具体指的是？中国医药回复：您好！公司全面推进科技创新，在仿制药、改良型新药、创新药研究方面均有布局。则正医药建立了复杂注射剂技术、难溶性药物增溶递送技术、缓控释技术、药械组合技术、儿童药物研发创新技术、速释制剂技术、口服多肽技术以及原料合成技术八大核心自主研发平台；丽益科技专注于化学药物、中药及天然药物、药物新制剂、新工艺以及保健品研发。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","600056","BK0250","BK0082","BK0175","BK0028","BK0010","BK0188","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484013","title":"佳兆业健康(00876)：中文股份简称将更改为“青海生物制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484013?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:44","pubTimestamp":1790174658,"startTime":"0","endTime":"0","summary":"更改公司名称后，于香港联交所买卖股份之英文股份简称将由“KAISA HEALTH”更改为“QH BIO PHARMA”，而中文股份简称将由“佳兆业健康”更改为“青海生物制药”，自2026年9月28日上午九时正起生效。本公司于香港联交所之股份代号保持不变，仍为“876”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1239","BK1222","BBP","BK1230","00876","IBBQ","BK1154","03069","02954","MRNY","MRNX","BK1121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669610950","title":"中国医药：上半年度国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669610950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669610950?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:30","pubTimestamp":1790152227,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：3月2日的中国医药保健品进出口商会交流，公司营收实现了较块增长，请问近年公司营收不断萎缩，这个较快增长指的是什么？既然实现了较快增长为什么二季度主业务板块基本都下降中国医药回复：您好！公司持续深耕重点海外市场，积极拓展进口内贸业务，上半年度国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300027774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0175","03069","BK0028","BK0185","BK0082","BK0188","600056","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669712999","title":"股市必读：中国医药（600056）9月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669712999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669712999?lang=zh_cn&edition=full","pubTime":"2026-09-23 01:46","pubTimestamp":1790099178,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，中国医药报收于9.05元，下跌0.55%，换手率0.54%，成交量8.14万手，成交额7383.58万元。董秘最新回复投资者： 近期看到公司获得了不少奖项，增强了公司的实力，公司业绩应该蒸蒸日上？投资者： 1.第24届世界制药原料中国展，则正医药携复杂制剂、儿药、口服缓控释等六大核心技术平台亮相，吸引众多新老客户、行业同仁驻足交流。当日关注点交易信息汇总：9月22日主力资金净流出767.29万元，占总成交额10.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","BK0185","600056","BK0010","BK0028","BK0250","BK0082","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669211201","title":"中国医药：公司坚持稳中求进，以科技创新为引领，加快转型升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669211201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669211201?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:25","pubTimestamp":1790065519,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：近期看到有投资者质疑公司的奋斗目标和导向，请问公司如何打消投资者的质疑？中国医药回复：您好！公司坚持稳中求进，以科技创新为引领，加快转型升级。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200027418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0082","BK0175","BK0188","BK0010","BK0028","BK0185","BK0250","03069","600056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669056112","title":"中国医药：公司获得的各类奖项是行业及社会对公司的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2669056112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669056112?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:24","pubTimestamp":1790065463,"startTime":"0","endTime":"0","summary":"证券之星消息，中国医药(600056)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：近期看到公司获得了不少奖项，增强了公司的实力，公司业绩应该蒸蒸日上？请问公司近期的业绩如何？这些奖项有没有起到作用？中国医药回复：您好！公司获得的各类奖项是行业及社会对公司的认可，有助于提升公司品牌形象与行业影响力。公司将持续深耕主业，把品牌荣誉转化为经营动力。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200027330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0175","BK0028","600056","BK0082","03069","BK0010","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669130538","title":"野村：中国医药“十五五”规划突出创新与全球化 利好创新药企及CRDMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669130538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669130538?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:47","pubTimestamp":1789969625,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03069","06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668075449","title":"生物制药企业Electra美股上市：募资3.5亿美元 上半年亏4891万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668075449","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668075449?lang=zh_cn&edition=full","pubTime":"2026-09-20 10:32","pubTimestamp":1789871555,"startTime":"0","endTime":"0","summary":"生物制药企业Electra Therapeutics（股票代码：“ETRA”）日前在美国纳斯达克上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260920/6392549715050864394546786.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35194/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BBP","IBBQ","IPOS","MRNY","MRNX","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668909545","title":"每周股票复盘：中国医药（600056）国贸板块H1营收24.59亿增8.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668909545","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668909545?lang=zh_cn&edition=full","pubTime":"2026-09-20 02:01","pubTimestamp":1789840869,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，中国医药报收于8.94元，较上周的8.91元上涨0.34%。本周，中国医药9月14日盘中最高价报8.99元。9月16日盘中最低价报8.8元。中国医药当前最新总市值133.73亿元，在医药商业板块市值排名7/32，在两市A股市值排名1424/5220。2026年上半年，公司国际贸易板块实现主营业务收入24.59亿元，同比增长8.60%。2026年上半年，公司深入践行乡村振兴战略，立足武川中药材资源，推动帮扶由“输血”转向长效“造血”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03069","600056"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":-0.1186},{"period":"3month","weight":0.0253},{"period":"6month","weight":-0.0351},{"period":"1year","weight":-0.0628},{"period":"ytd","weight":0.0153}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"子基金的投资目标为提供紧贴指数表现的投资回报（未扣除费用及开支）。并不保证子基金能否达致其投资目标。子基金的指数经证监会事先批准及知会基金单位持有人后可更改。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.040155},{"month":2,"riseRate":0.4,"avgChangeRate":0.03003},{"month":3,"riseRate":0.2,"avgChangeRate":-0.029137},{"month":4,"riseRate":0.833333,"avgChangeRate":0.013346},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.016542},{"month":6,"riseRate":0.5,"avgChangeRate":0.022933},{"month":7,"riseRate":0.666667,"avgChangeRate":0.035744},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011048},{"month":9,"riseRate":0.5,"avgChangeRate":0.034327},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.059706},{"month":11,"riseRate":0.6,"avgChangeRate":0.051035},{"month":12,"riseRate":0.2,"avgChangeRate":-0.056464}],"exchange":"SEHK","name":"华夏恒生生科","nameEN":"CAM HSBIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华夏恒生生科,03069,华夏恒生生科股票,华夏恒生生科股票老虎,华夏恒生生科股票老虎国际,华夏恒生生科行情,华夏恒生生科股票行情,华夏恒生生科股价,华夏恒生生科股市,华夏恒生生科股票价格,华夏恒生生科股票交易,华夏恒生生科股票购买,华夏恒生生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华夏恒生生科(03069)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华夏恒生生科(03069)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}